In the century since the move to Memphis from Clarksville, Rhodes has thrived and ranked nationally as one of the country's ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Watson Davis (1896-1967), who became ...

Explore the all-new 2024 Toyota Prius Prime plug-in hybrid, combining efficiency with updated styling and advanced technology. This review highlights its driving experience, electric range, interior ...

Combined treatments for both aspects of obstructive sleep apnea (OSA)—a compromised airway anatomy and unstable ...

Telitacicept, a new dual inhibitor of the cytokines B-lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand ...

This was supposed to be a normal day of magnet fishing. Instead, it became my best find yet two swords pulled from the same spot. The weight of history was in my hands, and the moment felt like ...

The Federal Trade Commission’s long-awaited trial against Amazon begins this week, with the e-commerce giant’s cancellation practices under the microscope. The lawsuit, filed in 2023 under the Biden ...

OPENING STATEMENTS. ALANNA. JEANNE. OPENING STATEMENTS JUST WRAPPED UP IN THAT CROWDED COURTROOM. BOTH SIDES MAKING THEIR CASE TO THE JURY. ONE SIDE MAINTAINING THAT JAMES WOODLOCK IS INNOCENT OF ...

Patrick Spradlin portrays defense attorney Clarence Darrow in the one-man play, Clarence Darrow. The play will tour Iowa in October. The performances, presented by the Iowa Labor History Society, aim ...

Amazon faces a court hearing in Seattle this week to face allegations by federal regulators that the e-commerce giant duped customers into signing up for its Prime membership while also making it ...

The Supreme Court Can Choose to Clarify Election Laws in Advance Brightline Touches the Third Rail A Preposterous Legal Assault Against Fossil Fuels Will D.C. Bureaucrats Shut Down the District’s ...

Eli Lilly has pulled the plug on a phase 2b obesity trial before enrolling a single patient, citing “strategic business reasons.” The study was designed to test bimagrumab, an asset Lilly acquired in ...